284 related articles for article (PubMed ID: 36094217)
1. Sequence Type 5 (ST5) as a Possible Predictor of Bacterial Persistence in Adult Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia Treated with Vancomycin.
Fan YX; Chen MT; Li NY; Liu XF; Yang MJ; Chen YC; Liang XY; Wu JF; Guo BN; Song SC; Zhu YQ; Zhang FY; Hang JQ; Wu SB; Shen B; Li HY; Wang Q; Luo XM; Chen QG; Zhang HF; Wang RL; Shen LH; Fu FM; Song XL; Zhang J
Microbiol Spectr; 2022 Oct; 10(5):e0134822. PubMed ID: 36094217
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of vancomycin in treating ST5 and ST764 methicillin-resistant
Fan Y; Zhang K; Chen M; Li N; Liu X; Yang M; Liang X; Wu J; Guo B; Zheng H; Zhu Y; Zhang F; Hang J; Zhang H; Wang R; Yuan Q; Song X; Wu S; Shen B; Zhang J
mSphere; 2023 Dec; 8(6):e0045723. PubMed ID: 37905831
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and molecular characteristics of heterogeneous vancomycin intermediate Staphylococcus aureus in a tertiary care center of northern China.
Cheng X; Ma L; Wang Y; Sun W; Su J
Diagn Microbiol Infect Dis; 2024 Mar; 108(3):116180. PubMed ID: 38183897
[TBL] [Abstract][Full Text] [Related]
4. Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus: Does Vancomycin Heteroresistance Matter?
Claeys KC; Lagnf AM; Hallesy JA; Compton MT; Gravelin AL; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Jan; 60(3):1708-16. PubMed ID: 26729497
[TBL] [Abstract][Full Text] [Related]
5. Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections.
Sivori F; Cavallo I; Kovacs D; Guembe M; Sperduti I; Truglio M; Pasqua M; Prignano G; Mastrofrancesco A; Toma L; Pimpinelli F; Morrone A; Ensoli F; Di Domenico EG
Microbiol Spectr; 2022 Apr; 10(2):e0035122. PubMed ID: 35416701
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care units.
Hu HC; Kao KC; Chiu LC; Chang CH; Hung CY; Li LF; Liu TP; Lin LC; Chen NH; Huang CC; Yang CT; Lu JJ
BMC Infect Dis; 2015 Oct; 15():444. PubMed ID: 26497595
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Molecular Epidemiology of an Emerging Panton-Valentine Leukocidin-Positive ST5 Methicillin-Resistant Staphylococcus aureus Clone in Northern Australia.
McGuinness SL; Holt DC; Harris TM; Wright C; Baird R; Giffard PM; Bowen AC; Tong SYC
mSphere; 2021 Feb; 6(1):. PubMed ID: 33568451
[TBL] [Abstract][Full Text] [Related]
8. Effects of sub-inhibitory concentrations of nafcillin, vancomycin, ciprofloxacin, and rifampin on biofilm formation of clinical methicillin-resistant
Park K-H; Kim D; Jung M; Kim DY; Lee Y-M; Lee MS; Hong K-W; Bae I-G; Hong SI; Cho O-H
Microbiol Spectr; 2024 Jun; 12(6):e0341223. PubMed ID: 38651875
[TBL] [Abstract][Full Text] [Related]
9. Molecular and Clinical Features of Heterogeneous Vancomycin-Intermediate
Sreejisha M; Shenoy MS; Shenoy MS; Dhanashree B; Chakrapani M; Bhat KG
Sultan Qaboos Univ Med J; 2023 Nov; 23(4):447-454. PubMed ID: 38090245
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.
Huang SH; Chen YC; Chuang YC; Chiu SK; Fung CP; Lu PL; Wang LS; Wu TL; Wang JT
J Microbiol Immunol Infect; 2016 Oct; 49(5):701-707. PubMed ID: 26320398
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic/Pharmacodynamic Target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant
Song X; Han M
Front Cell Infect Microbiol; 2022; 12():874401. PubMed ID: 35873144
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.
Casapao AM; Davis SL; McRoberts JP; Lagnf AM; Patel S; Kullar R; Levine DP; Rybak MJ
Antimicrob Agents Chemother; 2014 Aug; 58(8):4636-41. PubMed ID: 24890596
[TBL] [Abstract][Full Text] [Related]
13. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
Ghahremani M; Jazani NH; Sharifi Y
J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
[TBL] [Abstract][Full Text] [Related]
14. Impact of psm-mec in Methicillin-Resistant Staphylococcus aureus (ST764) Strains Isolated from Keratitis Patients.
Suzuki T; Yamamoto T; Kaito C; Miyamoto H; Ohashi Y
Microb Drug Resist; 2016 Oct; 22(7):589-597. PubMed ID: 26954266
[TBL] [Abstract][Full Text] [Related]
15. Clinical and microbiologic analysis of the risk factors for mortality in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia.
Chong YP; Park KH; Kim ES; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
Antimicrob Agents Chemother; 2015; 59(6):3541-7. PubMed ID: 25845875
[TBL] [Abstract][Full Text] [Related]
16. Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India.
Bakthavatchalam YD; Babu P; Munusamy E; Dwarakanathan HT; Rupali P; Zervos M; John Victor P; Veeraraghavan B
PLoS One; 2019; 14(12):e0227009. PubMed ID: 31887179
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant
Ozmen Capin BB; Tekeli A; Karahan ZC
Microb Drug Resist; 2020 Mar; 26(3):238-244. PubMed ID: 31545160
[No Abstract] [Full Text] [Related]
18. Etest Methods for Screening Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) strains.
Lee MY; Lee WI; Kim MH; Kang SY; Kim YJ
Curr Microbiol; 2020 Oct; 77(10):3158-3167. PubMed ID: 32734419
[TBL] [Abstract][Full Text] [Related]
19. Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006.
Chung G; Cha J; Han S; Jang H; Lee K; Yoo J; Yoo J; Kim H; Eun S; Kim B; Park O; Lee Ys
J Microbiol Biotechnol; 2010 Mar; 20(3):637-42. PubMed ID: 20372039
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus in Hokkaido, northern main island of Japan: identification of sequence types 6 and 59 Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus.
Kawaguchiya M; Urushibara N; Kuwahara O; Ito M; Mise K; Kobayashi N
Microb Drug Resist; 2011 Jun; 17(2):241-50. PubMed ID: 21395449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
